Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Dingell, Debbie [D-MI-6]

Rep. Dingell, Debbie [D-MI-6]

United States · Official source

Records

3,415 records where Rep. Dingell, Debbie [D-MI-6] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 4763 (119th)referred

PTO Act

United States · United States Congress · 25 July 2025

Bill· HRH.R. 4752 (119th)referred

Reducing Hereditary Cancer Act

United States · United States Congress · 23 July 2025

Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Bill· HRH.R. 4708 (119th)referred

Spotted Lanternfly Research and Development Act

United States · United States Congress · 23 July 2025

Spotted Lanternfly Research and Development Act This bill includes combatting the spotted lanternfly (Lycorma delicatula) as a Department of Agriculture (USDA) high-priority research and extension area and reauthorizes other USDA research and extension initiatives. The bill specifically allows grants for developing and disseminating research-based tools and treatments to combat the spotted lanternfly, which is an invasive species native to Asia that feeds on a wide range of crops and plants (e.g., grapes, apples, hops, walnuts, and hardwood trees). Further, the bill reauthorizes USDA grants to support competitive specialized research and extension activities, including high-priority areas, through FY2030. The bill also specifically reauthorizes through FY2030 the Pulse Crop Health Initiative; the Comprehensive Food Safety Training Network; pollinator protection research and extension grants; increased USDA capacity and infrastructure to address and conduct research on colony collapse disorder and other pollinator issues; and a USDA-conducted nationwide honey bee pest, pathogen, health, and population status surveillance program.

Bill· HRH.R. 4641 (119th)referred

Keep Kids Covered Act

United States · United States Congress · 23 July 2025

Bill· HRH.R. 4731 (119th)referred

Resident Physician Shortage Reduction Act of 2025

United States · United States Congress · 23 July 2025

Resident Physician Shortage Reduction Act of 2025 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for qualifying hospitals, including hospitals in rural areas and health professional shortage areas. The bill provides for an additional increase of 2,000 positions per fiscal year from FY2026-FY2032; during this period, each hospital may receive up to 75 additional positions in total under the bill and current law. Additionally, one-third of the positions that are made available under the bill must be allocated to hospitals that are already operating above applicable resident limits. The bill also requires the Government Accountability Office to report on strategies to increase the diversity of the health professional workforce, including with respect to representation from rural, low-income, and minority communities.

Bill· HRH.R. 4606 (119th)referred

Ally’s Act

United States · United States Congress · 22 July 2025

Bill· HRH.R. 4588 (119th)referred

Supporting Apprenticeship Colleges Act of 2025

United States · United States Congress · 22 July 2025

Supporting Apprenticeship Colleges Act of 2025 This bill directs the Department of Education to award grants to institutions of higher education that sponsor construction and manufacturing-oriented registered apprenticeship programs for (1) expanding or supporting outreach to high schools, local businesses, local workforce development boards, and apprenticeship intermediaries; and (2) providing advising and support services to students who are enrolled in these apprenticeship programs.

Bill· HRH.R. 4564 (119th)referred

Dillon’s Law

United States · United States Congress · 21 July 2025

Bill· HRH.R. 4482 (119th)referred

Stop NOAA Closures Act

United States · United States Congress · 17 July 2025

Bill· HRH.R. 4541 (119th)referred

To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.

United States · United States Congress · 17 July 2025

This bill reauthorizes and revises programs of the Centers for Disease Control and Prevention (CDC) that support services and education addressing breast and cervical cancer. The bill reauthorizes through FY2030 and makes changes to the CDC’s National Breast and Cervical Cancer Early Detection Program. This program provides grants to states for breast and cervical cancer screening, diagnostic, and treatment services for individuals who have low incomes, are uninsured, or otherwise lack access to such services. The bill increases flexibility in how states may spend grant funds under the program. The Government Accountability Office must report to Congress on the work of the National Breast and Cervical Cancer Early Detection Program, including the number of individuals served and barriers to accessing screenings. Also, the bill reauthorizes through FY2031 CDC programs relating to young women’s awareness of breast health and breast cancer. These programs include campaigns to educate young women and health care professionals, research on preventing breast cancer in younger women, and grants for resources and services to young women diagnosed with breast cancer and precancerous conditions.

Bill· HRH.R. 4484 (119th)referred

ADAPT Act

United States · United States Congress · 17 July 2025

Accelerating the Development of Advanced Psychology Trainees Act or the ADAPT Act This bill provides for Medicare coverage of services that are furnished by advanced psychology trainees. It also requires the Centers for Medicare & Medicaid Services to issue guidance for states on coverage options for such services under Medicaid and the Children's Health Insurance Program (CHIP).

Bill· HRH.R. 4434 (119th)referred

Cosmetic Supply Chain Transparency Act of 2025

United States · United States Congress · 16 July 2025

Cosmetic Supply Chain Transparency Act of 2025 This bill requires the Food and Drug Administration (FDA) to maintain a list of certain chemicals incidentally present in cosmetics, known as nonfunctional constituents , that are harmful to human health or the environment. The bill also imposes certain testing and disclosure requirements on cosmetics brand owners (i.e., entities bringing cosmetics to market) and suppliers of cosmetics, packaging, and ingredients. For each listed nonfunctional constituent, the FDA must identify the ingredient or cosmetic in which the constituent is known or reasonably expected to be present. The FDA must also (1) accept petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance. Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request. Brand owners and other entities in the supply chain of a cosmetic must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request. The bill also imposes civil penalties for entities that violate this bill's provisions.

Bill· HRH.R. 4436 (119th)referred

Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2025

United States · United States Congress · 16 July 2025

Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2025 This bill establishes programs and requirements to address the effects of harmful chemicals in cosmetics on consumers and salon workers, particularly in communities of color, and subjects synthetic braids to regulation by the Food and Drug Administration (FDA). Specifically, the FDA must establish safety standards for synthetic braids. Synthetic braids that do not meet such standards must be labeled with a specified warning. The bill also requires the Department of Health and Human Services (HHS) to conduct (or award grants for) research on harmful chemicals most commonly found in cosmetics marketed to and used by women and girls of color and professional nail, hair, and beauty salon workers. HHS must publish reports summarizing this research, including recommendations for reducing potentially unsafe exposures. In addition, the FDA must award grants to support the development of alternative, safer chemicals that may be used in place of harmful chemicals in cosmetics. HHS must also establish, through grants to eligible entities, national resource centers on beauty justice and salon worker health and safety to educate consumers and salon workers, respectively, about harmful chemicals in cosmetics. Finally, the Occupational Safety and Health Administration must require manufacturers and importers of professional cosmetic products to make safety data sheets available in multiple languages for cosmetics that include certain hazardous chemicals. Employers, including salon operators, must make the relevant safety data sheet available to any employee exposed to a product subject to this requirement.

Bill· HRH.R. 4435 (119th)referred

Cosmetic Hazardous Ingredient Right to Know Act of 2025

United States · United States Congress · 16 July 2025

Cosmetic Hazardous Ingredient Right to Know Act of 2025 This bill requires cosmetic products to be labeled with a full list of their ingredients, including fragrance and flavor ingredients, and imposes other disclosure and labeling requirements related to certain potentially harmful ingredients. A cosmetic product that fails to meet such requirements may not be sold. Under current law, a cosmetic product’s packaging must generally include a list of its ingredients, but fragrance or flavor ingredients may be listed as fragrance or flavor in lieu of listing specific ingredient names. Within two years of the bill’s enactment, a cosmetic product's labeling or packaging must include a full list of its ingredients, including fragrance and flavor ingredients. Further, if the cosmetic includes certain ingredients, its labeling or packaging must also contain a specified statement directing consumers to the brand owner's website for information on health impacts of the product’s ingredients. Ingredients that trigger this requirement include those identified on specified lists of harmful or potentially harmful chemicals, such as chemicals identified as carcinogenic by the Environmental Protection Agency. The Food and Drug Administration must maintain a public list of all such ingredients. Within one year of enactment, a brand owner must disclose certain information on its website for each of its cosmetic products, including a full list of ingredients; the functional purpose served by each fragrance or flavor ingredient; and if any ingredient is identified on the specified lists of harmful or potentially harmful chemicals, a link to the relevant list.

Resolution· HRESH.Res. 581 (119th)open

Providing for consideration of the bill (H.R. 185) to advance responsible policies.

United States · United States Congress · 15 July 2025

This resolution provides a special rule for consideration of H.R. 185 and amends that bill to direct the Department of Justice (DOJ) to make publicly available certain records related to Jeffrey Epstein or Ghislaine Maxwell. Under H.R. 185, as amended by the resolution, DOJ must publicly disclose all unclassified records, documents, communications, and investigative materials in its possession that relate to Epstein or Maxwell. The records include unclassified records referring or relating to Epstein's detention and death; flight logs of aircraft owned or used by Epstein; individuals named in connection with Epstein’s criminal activities, civil settlements, or immunity or plea agreements; immunity deals, sealed settlements, or plea bargains of Epstein or his associates; entities with ties to Epstein’s trafficking or financial networks; and internal Department of Justice communications concerning decisions to investigate or charge Epstein or his associates.  However, under the amended bill, DOJ may withhold or redact portions of records with written justification that such portions contain (1) victims' personally identifiable information; (2) child sexual abuse materials; (3) images of death, physical abuse, or injury; (4) information which would jeopardize an active federal investigation or prosecution; or (5) classified information. DOJ may not withhold or redact records on the basis of embarrassment, reputational harm, or political sensitivity. Further, within 15 days of completing the required disclosures, DOJ must provide Congress with a report listing all categories of records released and withheld, all redactions made and their legal basis, and all government officials and politically exposed persons named or referenced in the released materials.

Law· HRH.R. 4323 (119th)enacted

Trafficking Survivors Relief Act

United States · United States Congress · 10 July 2025

Trafficking Survivors Relief Act of 2025 This bill establishes a process to vacate convictions and expunge arrest records for certain criminal offenses committed by victims of human trafficking that directly result from or relate to having been a trafficking victim. It defines the offenses eligible to be vacated or expunged and sets forth procedures for filing a motion. The Government Accountability Office must assess the impact of this process, including the number of human trafficking survivors who file motions to vacate convictions or expunge records. The bill permits certain grants for legal representation to be used to seek post-conviction relief. Finally, the bill allows a defendant to establish that the offenses were committed under duress by demonstrating that he or she was a victim of human trafficking at the time of the offense.

Bill· HRH.R. 4317 (119th)referred

PBM Reform Act of 2025

United States · United States Congress · 10 July 2025

Bill· HRH.R. 4273 (119th)open

Over-the-Counter Monograph Drug User Fee Amendments

United States · United States Congress · 2 July 2025

Over-the-Counter Monograph Drug User Fee Amendments This bill reauthorizes the Over-the-Counter (OTC) Monograph Drug User Fee Program (OMUFA) through FY2030 and revises certain aspects of the program, including total fees to be collected and fee due dates. Under current law, many OTC drugs are marketed through compliance with an OTC monograph issued by the Food and Drug Administration (FDA), rather than through an approved new drug application. Monographs establish the conditions under which OTC drugs are generally recognized as safe and effective, and include ingredients, dosages, and other requirements. OMUFA permits the FDA to collect fees from OTC drug facilities and entities requesting changes to a monograph. The bill makes certain changes to OMUFA, including by revising the total facility fee revenue amount to be collected for FY2026-FY2030, revising due dates for facility fees, permitting the FDA to implement a one-time adjustment to facility fees if certain conditions exist, and requiring the FDA to publish facility and order request fee amounts at least 60 days before the start of each fiscal year. Finally, the bill adds as a Tier 2 OTC monograph order request a request for the addition or modification of a testing procedure applicable to a monograph drug, provided the testing procedure reflects a voluntary consensus standard with respect to pharmaceutical quality. (Requestors seeking certain kinds of changes to a monograph are awarded a period of market exclusivity if the FDA makes the requested changes; tier 2 requests are not eligible for market exclusivity.)

Resolution· HRESH.Res. 565 (119th)referred

Expressing support for the designation of the week of June 30 through July 4, 2025, as "National Tire Safety Week" in the United States, and supporting the goals and ideals of "National Tire Safety Week" to educate American motorists about the importance of proper tire care and maintenance.

United States · United States Congress · 30 June 2025

This resolution supports the designation of National Tire Safety Week. The resolution also encourages people to educate themselves and others on the importance of regularly inspecting and maintaining a vehicle's tires.

Bill· HRH.R. 4244 (119th)referred

Prohibition of Medicaid Funding for Conversion Therapy Act

United States · United States Congress · 27 June 2025

Prohibition of Medicaid Funding for Conversion Therapy Act This bill prohibits state Medicaid programs from covering conversion therapy. The bill defines conversion therapy as any practice or treatment that seeks to change a person's sexual orientation or gender identity in exchange for monetary compensation.

Bill· HRH.R. 4166 (119th)referred

Strengthening Protections for Domestic Violence and Stalking Survivors Act of 2025

United States · United States Congress · 26 June 2025

Strengthening Protections for Domestic Violence and Stalking Survivors Act of 2025 This bill extends federal restrictions on the receipt, possession, shipment, and transportation of firearms and ammunition to new types of stalking and domestic violence offenders. Specifically, the bill extends federal firearms-related restrictions to individuals who are convicted of a misdemeanor crime of stalking. The term misdemeanor crime of stalking means a federal, state, tribal, or local offense involving harassment, intimidation, or surveillance that (1) causes emotional distress; or (2) places a person in reasonable fear of harm to themselves, an immediate family member, a current or former cohabitant, an intimate partner, or a pet. Additionally, the bill extends federal firearms-related restrictions to individuals who are subject to a domestic violence protection order that restrains them from harassing, stalking, or threatening a current or former dating partner (regardless of when the relationship occurred) or an individual similarly situated to a spouse. Currently, the restrictions only apply if the domestic violence protection order restrains the individual from harassing, stalking, or threatening a co-parent, a current or former spouse, or a current or former cohabitant. Finally, the bill extends federal firearms-related restrictions to individuals who commit a misdemeanor crime of domestic violence against the child of a current or recent former dating partner. Currently, the restrictions only apply if the offense is committed against a current or recent former dating partner.

Bill· HRH.R. 12 (119th)referred

Women’s Health Protection Act of 2025

United States · United States Congress · 24 June 2025

Women's Health Protection Act of 2025 This bill prohibits governmental restrictions on the provision of, and access to, abortion services. Before fetal viability, governments may not restrict providers from using particular abortion procedures or drugs, offering abortion services via telemedicine, or immediately providing abortion services if delaying risks the patient's health. Furthermore, governments may not require providers to perform unnecessary medical procedures, provide medically inaccurate information, or comply with credentialing or other conditions that do not apply to providers who offer medically comparable services to abortions. Additionally, governments may not require patients to make medically unnecessary in-person visits before receiving abortion services or disclose their reasons for obtaining services. After fetal viability, governments may not restrict providers from performing abortions when necessary to protect a patient's life and health. The same provisions that apply to abortions before viability also apply to necessary abortions after viability. Additionally, states may authorize post-viability abortions in circumstances beyond those that the bill considers necessary. Further, the bill recognizes an individual's right to interstate travel, including for abortion services. The bill also prohibits governments from implementing measures that are similar to those restricted by the bill or that otherwise target and impede access to abortion services, unless the measure significantly advances the safety of abortion services or health of patients and cannot be achieved through less restrictive means. The Department of Justice, individuals, or providers may sue states or government officials to enforce this bill, regardless of certain immunity that would otherwise apply.